Vascular Pathways, Inc., a privately held medical device manufacturer with a revolutionary product for peripheral intravenous access, today announced that the company has elected Bill Bold as Executive Vice-President Sales and Marketing. Vascular Pathways recently completed a $13.5 million financing from leading venture capital firms CHL Medical Partners, Ascension Health Ventures, MVM Life Sciences, and Arcus Ventures.
Bill Bold has a long history as a senior executive in the medical device industry, compiling a successful track record in both early stage companies and in corporate operating divisions. Most recently Bill Bold was President of Access Scientific responsible for capital acquisition and the commercialization of multiple Vascular Access devices. From 2001 to 2006, he was the Senior Vice-President at Venetec International, a venture capital backed manufacturer of the StatLock® IV securement device, which was successfully sold to C.R. Bard in 2006 for $168 million. Before joining Venetec, he was Senior Vice-President of Medibuy.com an e-commerce company founded and devoted to the Medical Device Industry. Prior to that, he spent 11 years with CR Bard in a variety of general management and sales executive positions.
“We are very excited to have attracted an EVP of Bill Bold’s caliber to Vascular Pathways. We look forward to working with Bill to make the Accucath Intravenous Catheter System a successful product that benefits patients across the U.S. and internationally,” said Gene Starr, Vascular Pathways’ President and CEO.
“Dr. Amir Belson, Vascular Pathway’s Founder, and his colleagues have developed a truly novel product which has the potential to widely improve patient outcomes related to vascular access. I am very pleased to join the Vascular Pathways team in making AccuCath a success in this large and important market,” remarked Bill Bold, Vascular Pathways Executive Vice-President.
About Vascular Pathways, Inc.
Vascular Pathways is a private medical device company founded in 2005 which is commercializing the Accucath Intravenous Catheter System, an FDA approved innovative product enabling rapid, safe, and successful IV insertion. For further information about Vascular Pathways or the AccuCath device, please contact Bill Bold via e-mail at BBold(at)Vascularpathways(dot)com, telephone 561-573-5360 .